<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01564498</url>
  </required_header>
  <id_info>
    <org_study_id>2012MeckPurpleVeg</org_study_id>
    <nct_id>NCT01564498</nct_id>
  </id_info>
  <brief_title>Effects of Purple Vegetables on Cardiovascular Disease (CVD) Risk Factors</brief_title>
  <official_title>A Pilot Study of the Effects of Replacing Orange Carrots and White Potatoes With Purple Varieties, on Risk Factors for Cardiovascular Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Guelph</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ontario Ministry of Agriculture, Food and Rural Affairs</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Guelph</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis is that richly coloured purple vegetables, rich in polyphenolic compounds
      including anthocyanins will have higher antioxidant and other biological activities, than
      more lightly coloured versions of these foods. Diets of human subjects will be modified to
      allow consumption of 200-300 g of raw carrots or cooked potatoes. Participants will be
      randomized to consume either orange or purple carrots, or white or purple potatoes. They will
      consume these diets for 12 weeks and bioavailability of polyphenolics will be examined as
      well as anthropometry and blood biochemistry for changes in risk factors associated with
      cardiovascular disease.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood cholesterol</measure>
    <time_frame>12 weeks</time_frame>
    <description>blood will be collected at baseline before the experimental foods are introduced and again 6 weeks into the intervention period and during the last week of the intervention (week 12)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood pressure</measure>
    <time_frame>12 weeks</time_frame>
    <description>Participants will have their body weight and blood pressure taken at weekly counselling sessions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body composition</measure>
    <time_frame>12 weeks</time_frame>
    <description>body composition will be measured in well hydrated subjects using bioelectric impedence analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>insulin resistance</measure>
    <time_frame>12 weeks</time_frame>
    <description>insulin resistance will be measured by way of an oral glucose tolerance test and collection of venous blood samples for the subsequent 3 hours on two occasions, baseline and during the last week of the intervention diet.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood and urinary polyphenol metabolites</measure>
    <time_frame>12 weeks</time_frame>
    <description>venous blood and urine will be collected to determine the metabolic profiles of polyphenolics in individual participants.
Based on intake data, the bioavailability of the polyphenols in the foods will be estimated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>circulating biomarkers of cardiovascular disease and type II diabetes risk</measure>
    <time_frame>12 weeks</time_frame>
    <description>Blood will be collected for measurement of multiple cytokines, growth factors and other blood biomarkers associated with these diseases.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hypertension</condition>
  <condition>Hypercholesterolemia</condition>
  <condition>Type II Diabetes</condition>
  <condition>Obesity</condition>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>White potato</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will consume 300-500 g of cooked white potatoes per day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Purple Potato</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will consume 300-500 g of cooked purple potato per day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Orange carrots</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will consume 200-300 g typical varieties of orange carrots during the intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Purple Carrots</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will consume 200-300 g raw purple carrots instead of orange carrots in the control arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>vegetable</intervention_name>
    <description>200-300 g raw carrots or 300-500 g cooked potatoes</description>
    <arm_group_label>White potato</arm_group_label>
    <arm_group_label>Purple Potato</arm_group_label>
    <arm_group_label>Orange carrots</arm_group_label>
    <arm_group_label>Purple Carrots</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult men and women 18-65 years of age

          -  must have a least one of the following risk factors associated with increased risk of
             type II diabetes and/or cardiovascular disease:

               -  borderline high or hypertension or undergoing treatment for such

               -  abnormal fasting blood glucose or undergoing treatment for such

               -  overweight or obese

               -  borderline high or high LDL-cholesterol or undergoing treatment for such

               -  borderline low or low HDL-cholesterol

               -  borderline high or high triglycerides or undergoing treatment for such

        Exclusion Criteria:

          -  smokers, pregnant or nursing women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kelly A Meckling, PhD</last_name>
    <phone>5198244120</phone>
    <phone_ext>53742</phone_ext>
    <email>kmecklin@uoguelph.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Saqib Mannan, BSc</last_name>
    <phone>5198244120</phone>
    <phone_ext>53728</phone_ext>
    <email>smannan@uoguelph.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Human Nutraceutical Research Unit</name>
      <address>
        <city>Guelph</city>
        <state>Ontario</state>
        <zip>N1G2W1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda J Wright, PhD</last_name>
      <phone>5198244120</phone>
      <phone_ext>54697</phone_ext>
      <email>ajwright@uoguelph.ca</email>
    </contact>
    <contact_backup>
      <last_name>Amy Tucker, PhD</last_name>
      <phone>5198244120</phone>
      <phone_ext>53925</phone_ext>
    </contact_backup>
    <investigator>
      <last_name>Kelly A Meckling, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Saqib Mannan, BSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ricky Janssen, BSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2012</study_first_submitted>
  <study_first_submitted_qc>March 23, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 27, 2012</study_first_posted>
  <last_update_submitted>October 24, 2016</last_update_submitted>
  <last_update_submitted_qc>October 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Guelph</investigator_affiliation>
    <investigator_full_name>Kelly Anne Meckling, PhD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>anthocyanins</keyword>
  <keyword>antioxidant</keyword>
  <keyword>polyphenols</keyword>
  <keyword>bioavailability</keyword>
  <keyword>cholesterol</keyword>
  <keyword>insulin sensitivity</keyword>
  <keyword>glucose tolerance</keyword>
  <keyword>atherosclerosis</keyword>
  <keyword>metabolic syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Hypercholesterolemia</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

